Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
2.49
↑ 38% above average
Average (9y)
1.81
Historical baseline
Range
High:3.21
Low:0.57
CAGR
-1.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.49 | +162.9% |
| 2023 | 0.95 | +65.2% |
| 2022 | 0.57 | -65.6% |
| 2021 | 1.67 | -43.0% |
| 2020 | 2.93 | +189.2% |
| 2019 | 1.01 | +37.9% |
| 2018 | 0.73 | -55.5% |
| 2017 | 1.65 | -48.5% |
| 2016 | 3.21 | +10.3% |
| 2015 | 2.91 | - |